Lipoxin A4 Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis via Promoting the Regression of Inflammation

References

• Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945–1960. doi:10.1001/jama.2020.4006
   PubMed Web of Science ®Google Scholar
• Di Cesare A, Di Meglio P, Nestle FO. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 2009;129(6):1339–1350. doi:10.1038/jid.2009.59
   PubMed Web of Science ®Google Scholar
• Blauvelt A. T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis. J Invest Dermatol. 2008;128(5):1064–1067. doi:10.1038/jid.2008.85
   PubMed Web of Science ®Google Scholar
• Griffiths CEMC, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021;397(10281):1301–1315. doi:10.1016/S0140-6736(20)32549-6
   PubMed Web of Science ®Google Scholar
• van der Fits L, Mourits S, Voerman JSA, et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol. 2009;182(9):5836–5845. doi:10.4049/jimmunol.0802999
   PubMed Web of Science ®Google Scholar
• Cai Y, Shen X, Ding C, et al. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity. 2011;35(4):596–610. doi:10.1016/j.immuni.2011.08.001
   PubMed Web of Science ®Google Scholar
• Fujiyama T, Ito T, Umayahara T, et al. Topical application of a vitamin D3 analogue and corticosteroid to psoriasis plaques decreases skin infiltration of TH17 cells and their ex vivo expansion. J Allergy Clin Immunol. 2016;138(2):517–528. doi:10.1016/j.jaci.2016.03.048
   PubMed Web of Science ®Google Scholar
• Zhao J, Di T, Wang Y, et al. Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion. Eur J Pharmacol. 2016;772:131–143. doi:10.1016/j.ejphar.2015.12.040
   PubMed Web of Science ®Google Scholar
• Shibata S, Tada Y, Hau CS, et al. Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells. Nat Commun. 2015;6:7687. doi:10.1038/ncomms8687
   PubMed Web of Science ®Google Scholar
• Ramírez-Valle F, Gray EE, Cyster JG. Inflammation induces dermal Vγ4+ γδT17 memory-like cells that travel to distant skin and accelerate secondary IL-17-driven responses. Proc Natl Acad Sci U S A. 2015;112(26):8046–8051. doi:10.1073/pnas.1508990112
   PubMed Web of Science ®Google Scholar
• Mabuchi T, Takekoshi T, Hwang ST. Epidermal CCR6+ γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis. J Immunol. 2011;187(10):5026–5031. doi:10.4049/jimmunol.1101817
   PubMed Web of Science ®Google Scholar
• Gilbert NC, Newcomer ME, Werz O. Untangling the web of 5-lipoxygenase-derived products from a molecular and structural perspective: the battle between pro- and anti-inflammatory lipid mediators. Biochem Pharmacol. 2021;193:114759. doi:10.1016/j.bcp.2021.114759
   PubMed Web of Science ®Google Scholar
• Mei HX, Ye Y, Xu HR, et al. LXA4 inhibits lipopolysaccharide-induced inflammatory cell accumulation by resident macrophages in mice. J Inflamm Res. 2021;14:1375–1385. doi:10.2147/JIR.S301292
   PubMed Web of Science ®Google Scholar
• Pan WH, Hu X, Chen B, Xu QC, Mei HX. The effect and mechanism of lipoxin A4 on neutrophil function in LPS-induced lung injury. Inflammation. 2022;45(5):1950–1967. doi:10.1007/s10753-022-01666-5
   PubMed Web of Science ®Google Scholar
• Chen Y, Zheng Y, Xin L, et al. 15-epi-lipoxin A4 inhibits TNF-α-induced tissue factor expression via the PI3K/AKT/NF-κB axis in human umbilical vein endothelial cells. Biomed Pharmacother. 2019;117:109099. doi:10.1016/j.biopha.2019.109099
   PubMed Web of Science ®Google Scholar
• Hu F, Liu X, Wang X, et al. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes associated with the ERK1/2 and NF-κB pathways. J Dermatol Sci. 2015;78(3):181–188. doi:10.1016/j.jdermsci.2015.03.009
   PubMed Web of Science ®Google Scholar
• Sekheri M, El Kebir D, Edner N, Filep JG. 15-Epi-LXA4 and 17-epi-RvD1 restore TLR9-mediated impaired neutrophil phagocytosis and accelerate resolution of lung inflammation. Proc Natl Acad Sci U S A. 2020;117(14):7971–7980. doi:10.1073/pnas.1920193117
   PubMed Web of Science ®Google Scholar
• Petri MH, Laguna-Fernandez A, Arnardottir H, et al. Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E−/− mice. Br J Pharmacol. 2017;174(22):4043–4054. doi:10.1111/bph.13707
   PubMed Web of Science ®Google Scholar
• Guo Y, Dong C, Tang J, et al. Lipoxin A4 alleviates cerebral ischemia-reperfusion injury through up-regulating Nrf2. J Neurosurg Sci. 2018;62(2):225–226. doi:10.23736/S0390-5616.17.04164-9
   PubMed Web of Science ®Google Scholar
• Wang X, Miao Z, Xu X, Schultzberg M, Zhao Y. Reduced levels of plasma lipoxin A4 are associated with post-stroke cognitive impairment. J Alzheimers Dis. 2021;79(2):607–613. doi:10.3233/JAD-201050
   PubMed Web of Science ®Google Scholar
• Queck A, Fink AF, Sirait-Fischer E, et al. Alox12/15 deficiency exacerbates, while lipoxin A4 ameliorates hepatic inflammation in murine alcoholic hepatitis. Front Immunol. 2020;11:1447. doi:10.3389/fimmu.2020.01447
   PubMed Web of Science ®Google Scholar
• Kim SN, Akindehin S, Kwon HJ, et al. Anti-inflammatory role of 15-lipoxygenase contributes to the maintenance of skin integrity in mice. Sci Rep. 2018;8(1):8856. doi:10.1038/s41598-018-27221-7
   PubMedGoogle Scholar
• Wu RF, Huang ZX, Ran J, et al. Lipoxin A4 suppresses estrogen-induced epithelial-mesenchymal transition via ALXR-dependent manner in endometriosis. Reprod Sci. 2018;25(4):566–578. doi:10.1177/1933719117718271
   PubMed Web of Science ®Google Scholar
• Strober B, Stein Gold L, Bissonnette R, et al. One-year safety and efficacy of tapinar of cream for the treatment of plaque psoriasis: results from the PSOARING 3 trial. J Am Acad Dermatol. 2022;87(4):800–806. doi:10.1016/j.jaad.2022.06.1171
   PubMed Web of Science ®Google Scholar
• Campanati A, Paolinelli M, Diotallevi F, Martin E, Molinelli E, Offidani A. Pharmacodynamics of TNF-α inhibitors for the treatment of psoriasis. Expert Opin Drug Metab Toxicol. 2019;15(11):913–925. doi:10.1080/17425255.2019.1681969
   PubMed Web of Science ®Google Scholar
• Ghoreschi K, Balato A, Enerbäck C, Sabat R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet. 2021;397(10275):754–766. doi:10.1016/S0140-6736(21)00184-7
   PubMed Web of Science ®Google Scholar
• Cai Y, Xue F, Quan C, et al. A critical role of the IL-1β-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis. J Invest Dermatol. 2019;139(1):146–156. doi:10.1016/j.jid.2018.07.025
   PubMed Web of Science ®Google Scholar
• Wang A, Bai Y. Dendritic cells: the driver of psoriasis. J Dermatol. 2020;47(2):104–113. doi:10.1111/1346-8138.15184
   PubMed Web of Science ®Google Scholar
• Gray EE, Suzuki K, Cyster JG. Cutting edge: identification of a motile IL-17-producing gammadelta T cell population in the dermis. J Immunol. 2011;186(11):6091–6095. doi:10.4049/jimmunol.1100427
   PubMed Web of Science ®Google Scholar
• Liu N, Qin H, Cai Y, et al. Dynamic trafficking patterns of IL-17-producing γδ T cells are linked to the recurrence of skin inflammation in psoriasis-like dermatitis. EBioMedicine. 2022;82:104136. doi:10.1016/j.ebiom.2022.104136
   PubMed Web of Science ®Google Scholar
• Santos MRG, Queiroz-Junior CM, Madeira MFM, Machado FS. Suppressors of cytokine signaling (SOCS) proteins in inflammatory bone disorders. Bone. 2020;140:115538. doi:10.1016/j.bone.2020.115538
   PubMed Web of Science ®Google Scholar
• Hu F, Feng AP, Liu XX, et al. Lipoxin A4 inhibits lipopolysaccharide-induced production of inflammatory cytokines in keratinocytes by up-regulating SOCS2 and down-regulating TRAF6. J Huazhong Univ Sci Technolog Med Sci. 2015;35(3):426–431. doi:10.1007/s11596-015-1448-8
   PubMedGoogle Scholar
• Zhang M, Li N, Cai R, et al. Rosmarinic acid protects mice from imiquimod induced psoriasis-like skin lesions by inhibiting the IL-23/Th17 axis via regulating Jak2/Stat3 signaling pathway. Phytother Res. 2021;35(8):4526–4537. doi:10.1002/ptr.7155
   PubMed Web of Science ®Google Scholar
• Fu T, Mohan M, Brennan EP, et al. Therapeutic potential of lipoxin A4 in chronic inflammation: focus on cardiometabolic disease. ACS Pharmacol Transl Sci. 2020;3(1):43–55. doi:10.1021/acsptsci.9b00097
   PubMedGoogle Scholar